Maia biotechnology, inc.MAIA.US Overview
US StockHealthcare
(No presentation for MAIA)
MAIA Overall Performance
MAIA AI Analysis & Strategy
MAIA Recent Performance
0.71%
Maia biotechnology, inc.
0.81%
Avg of Sector
-1.14%
S&P500
MAIA PowerScanner
MAIA Key Information
MAIA Valuation Metrics
MAIA Earnings Table
MAIA Profile
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.